Rousselot, Darling Ingredients’ health brand, and a developer collagen products, has announced an increase in its production capabilities for porcine collagen, reportedly responding to rising demand. The production line in Ghent will specialise in the manufacture of Peptan P, the company’s collagen peptide brand. This line complements the company’s existing bovine and fish collagen production capabilities.
Consumer interest in collagen-based supplements is increasing around the world, with the category seeing a threefold increase in product launches from 2017–2021, according to Innova Market Insights.
Rousselot has increased its collagen peptide production facilities from two in 2019, to four sites; which now include this dedicated porcine collagen production facility in Ghent. The IFS, FASFC and HACCP certified site has specialised in porcine collagen extraction since 1962. Also housed alongside the production line at the site is the company’s expertise centre, where teams can access R&D and application labs, a sensory programme and a pilot hall.
The company says its porcine collagen platform offers a highly traceable, GMO-free source of collagen with a range of functional claims. what it calls an accessible, effective and adaptable ingredient as an alternative source of high-quality collagen.
Additionally, the company claims, the ingredient is highly bioavailable, cold water-soluble and with a completely neutral sensory profile, meaning it has broad potential in food, beverage and nutraceutical applications.
Gaetan Noiret, Global Director, Health and Nutrition at Rousselot said: “The addition of a new production line allows us to reach further with our customers, delivering the safe, traceable and science-backed collagen solutions they need to succeed in today’s market.” Noiret continues, “Our Ghent facility is perfectly positioned to produce first class collagen peptides of porcine origin - giving manufacturers the opportunity to diversify their offerings with accessible, world-leading ingredients supported by credible scientific research – ensuring a speedy path to market.”
The company is hosting a webinar entitled: New perspectives in the collagen world: premium porcine collagen peptides. The webinar is scheduled to take place on 22nd February 2022.